Global seroprevalence of Borrelia burgdorferi antibodies

14.5%

percent of people tested, worldwide (89 studies, 158,287 people)

“The reported estimated global Bb seroprevalence was 14.5% (95% CI 12.8% to 16.3%)”

BMJ Global Health 2022, Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis, 2022-06

Kind of source
Peer-reviewed study
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
Antibodies show past exposure, not current Lyme disease. The authors note possible false positives without Western blot confirmation and skew toward endemic areas.

Used in

Kept as evidence; no figure on the platform is computed from it yet.